Nausicaa Ventures
Nausicaa Ventures is a venture capital firm based in Louvain-la-Neuve, Belgium, established in 2009. The firm focuses on investments in early stage and early growth companies, specifically those completing Series C or Series D financing rounds, with investment amounts typically ranging from €1 million to €4 million. Nausicaa Ventures targets sectors such as healthcare, medical technologies, information and communications technology, manufacturing, and clean technology, primarily within a 300 km radius of Brussels, including regions in France, Luxembourg, the Netherlands, Switzerland, and the United Kingdom. The firm seeks opportunities where angel investors or family offices are already involved and has an average holding period of five years, aiming for exits within three to six years. Nausicaa Ventures was created by uniting 35 private investors and selected institutional investors, including the European Investment Fund, to bridge the equity gap for promising early-stage companies striving for profitable growth.
NGDATA develops data management systems. The company offers Lily, a big data management system that extracts business insights in real-time and benefits from enriched data in real-time. It serves retail and e-commerce; news, publishing, and media; finance, credit, and insurance; and telecom domains. The company is based in Ghent, Belgium with an additional office in Singapore; and Paris, France.
NGDATA develops data management systems. The company offers Lily, a big data management system that extracts business insights in real-time and benefits from enriched data in real-time. It serves retail and e-commerce; news, publishing, and media; finance, credit, and insurance; and telecom domains. The company is based in Ghent, Belgium with an additional office in Singapore; and Paris, France.
Ovizio Imaging Systems NV/SA specializes in the development of digital holographic interferometric microscopy products, creating advanced 4D microscopic imaging devices and software. Founded in 2009 and headquartered in Brussels, Belgium, the company offers a range of devices, including the oLine 4D, which requires no specific sample preparation and compensates for sample imperfections; the iLine 4D, designed for various applications such as flow monitoring and cell culture observation; and various specialized instruments like ILine F for real-time monitoring of suspension cell cultures and iLine M for assessing cell confluence in multi-layer vessels. Ovizio also provides OsOne software for the visualization, analysis, and archiving of captured images, alongside QMod, which integrates holographic and fluorescence microscopy. Its products are widely utilized by scientists in pharmaceutical and biotechnology research and development, facilitating advancements in automated cell culture monitoring and analysis.
NGDATA develops data management systems. The company offers Lily, a big data management system that extracts business insights in real-time and benefits from enriched data in real-time. It serves retail and e-commerce; news, publishing, and media; finance, credit, and insurance; and telecom domains. The company is based in Ghent, Belgium with an additional office in Singapore; and Paris, France.
Bone Therapeutics is a leading international biopharmaceutical company focused on innovative cell therapy products for the treatment of bone diseases. Utilizing the Company's unique knowledge of the bone/joint physiology and long-standing expertise in cell therapy and cell transplantation, Bone Therapeutics has created a fully integrated business with an advanced product pipeline comprising novel bone cell products, tailored in-house production methods, and minimally invasive treatment techniques.